Extended-Release Viloxazine for the Treatment of Attention-Deficit Hyperactivity Disorder in School-Age Children and Adolescents CONCLUSION: Viloxazine ER is a useful addition to other nonstimulant medications available to treat patients with ADHD. via https://pubmed.ncbi.nlm.nih.gov/37021356/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20230424010906&v=2.17.9.post6+86293ac